Introduction: Wide-neck aneurysms pose a daunting challenge to endovascular neurosurgeons. Thus, the Low-profile Visualized Intraluminal Support Junior (LVIS Jr) stent from MicroVention-Terumo has emerged as a promising treatment option. This meta-analysis aims to evaluate the usability and effectiveness of this technology in managing wide-neck aneurysms. Methods: We systematically searched in PubMed, Embase, and Web of Science databases, comprising studies with outcomes related to LVIS Jr use in wide-neck aneurysms. Data was extracted from the selected articles and subjected to statistical analysis. Additionally, the ROBINS-I tool was employed for quality assessment. Results: Among 886 initially identified articles, 20 studies met our inclusion criteria, comprising a total of 557 patients. Our analysis revealed a 96% final occlusion rate under common effects and 93% under random effects, with substantial heterogeneity (I² = 69%), and good clinical outcomes were observed in 99% of cases with low heterogeneity (I² = 27%). Mortality rates were extremely low, with only one reported death out of 499 patients across 18 studies, resulting in a 0% mortality rate for common and random effects, and no heterogeneity (I² = 0). Complications occurred in 44 of 482 patients, yielding a 6% rate in the common effect model and 6% in the random effects model, with nonsignificant heterogeneity (I² = 25%). Conclusion: A favorable rate of final occlusion and good clinical outcomes was observed with LVIS Jr. Moreover, the low mortality and complication rates highlight its safety.